Entalopin

Entalopin is a selective serotonin reuptake inhibitor (SSRI) antidepressant medication used to treat major depressive disorder, obsessive-compulsive disorder (OCD), panic disorder, social anxiety disorder, post-traumatic stress disorder (PTSD), and premenstrual dysphoric disorder (PMDD). It is available in tablet form and is typically taken orally once daily.

Entalopin was developed by the pharmaceutical company Lundbeck and was approved for medical use in the European Union in 2017. The drug works by increasing the levels of serotonin, a neurotransmitter, in the brain, which helps to improve mood and reduce symptoms of anxiety and depression.

Common side effects of entalopin include nausea, dizziness, drowsiness, and sexual dysfunction. Serious side effects may include suicidal thoughts or behaviors, serotonin syndrome, and an increased risk of bleeding. It is important to consult a healthcare provider before starting entalopin, as it may not be suitable for everyone, particularly those with a history of certain medical conditions or who are taking other medications.

Entalopin is generally well-tolerated, but like all medications, it may not be effective for everyone. It is important to follow the prescribed dosage and to report any side effects or concerns to a healthcare provider.